Shenzhen Tisenc Medical Devices Co., Ltd of Shenzhen at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Shenzhen Tisenc Medical Devices Co., Ltd

10G Kechuang Building, Quanzhi Science and Innovation Park, Shasong Road, 518104 Shenzhen
Telephone +86 755 36983631
Fax +86 755 36983631

This company is co-exhibitor of
e-LinkCare Meditech Co., Limited

Hall map

MEDICA 2019 hall map (Hall 1): stand B53

Fairground map

MEDICA 2019 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Diagnostic rapid tests

About us

Company details

Founded in 2015, Shenzhen Tisenc Medical Devices Co., Ltd. is a Sino-foreign joint venture。Located in Shenzhen Guangdong, Tisenc Medical devices delicate in the developing,manufacturing and global sales of chemiluminescence Immunology (CLIA) systems.Company provide the product of CLIA system, high-level POCT system and moleculardiagnostics solutions.
Tisenc now has R&D labs, GMP factory, Instrument factory for totally over 5000 square meters space. Andfully intellectual property right for product andtechnologies, company is fully independent for the R&D and production of product.
Tisenc’s core management team are from well-known listed companies at home and abroad.
More than 70% of the employees in the company have master’s degree or above.
Tisenc takes ‘Talent Achievement, Quality Casting Brand’ as the core values. We successfully developed the ACCRE““ Tisenc has the ISO13485 certification , and we will obtained EU CE certification and China CFDA registration certificate in succession
It takes both the flexible operation of small POCT products and the quality level of chemiluminescence detection systems for Tisenc’s single-used automated chemiluminescence immunoassay analyzer. Based on the innovative nature of the two, ACCRE system can satisfy the needs for various customer including emergency departments, STAT laboratories and core laboratories. POCT has a great market development prospect in the next few decades
With the industry-leading research and development technology, perfect standardized production management system, precise market positioning and humanized management philosophy, Tisenc is committed to becoming the leading company in the Point-of-Care Testing (POCT) Chemiluminescence Immunoassay (CLIA) platform.

More Less